You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

priming regimen

Showing 1 - 25 of 9,449
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Relapsed, Adult Trial in Suzhou (CDIAG regimen)

Completed
  • Acute Myeloid Leukemia, Relapsed, Adult
  • CDIAG regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Mar 16, 2022

Hiv Trial in United States (V3G CH848 Pr-NP1 60mcg, 3M-052-AF 5mcg, Alum 500 mcg)

Not yet recruiting
  • Hiv
  • V3G CH848 Pr-NP1 60mcg
  • +5 more
  • Birmingham, Alabama
  • +5 more
Jun 5, 2023

Neuromuscular Blockade Trial (Rocuronium priming dose)

Recruiting
  • Neuromuscular Blockade
  • Rocuronium priming dose
  • Taipei, Taiwan
    Taipei Medical University Hospital
Nov 27, 2022

Stroke Rehabilitation Trial in Taichung, Taipei (Mirror therapy (MT) priming with task-specific training, Mirror therapy priming

Completed
  • Stroke Rehabilitation
  • Mirror therapy (MT) priming with task-specific training
  • +2 more
  • Taichung, Taiwan
  • +1 more
Aug 11, 2022

Acute Myeloid Leukemia, Refractory Acute Leukemia, Relapsed Adult AML Trial in Suzhou (CAHAG regimen, Placebo regimen)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • CAHAG regimen
  • Placebo regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Oct 10, 2021

Multiple Myeloma Trial in Worldwide (Elranatamab)

Recruiting
  • Multiple Myeloma
  • Fort Collins, Colorado
  • +33 more
Aug 17, 2022

Hypercholesterolemia Trial in Sydney, Morayfield, Melbourne (VXX-401, Placebo)

Recruiting
  • Hypercholesterolemia
  • Sydney, New South Wales, Australia
  • +2 more
Mar 15, 2023

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Non-Hodgkin Lymphoma Trial in Dallas (Focal radiation therapy (RT))

Recruiting
  • Non-Hodgkin Lymphoma
  • Focal radiation therapy (RT)
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 8, 2022

Heart Valve Diseases Trial in Tehran (Six percent hydroxy ethyl starch 130/0.4, Ringer lactate)

Completed
  • Heart Valve Diseases
  • Six percent hydroxy ethyl starch 130/0.4
  • Ringer lactate
  • Tehran, Iran, Islamic Republic of
    Rajaie CMRC
Jan 23, 2022

Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

Recruiting
  • Refractory/Relapse Acute Myeloid Leukemia
  • Kunming, Yunnan, China
    Department of Hematology,920th Hospital of Joint Logistic Suppor
Mar 28, 2023

Missed Menstrual Period Trial in Mexico City (Levonorgestrel, Mifepristone)

Recruiting
  • Missed Menstrual Period
  • Mexico City, Mexico
    Cuidado Integral de la Mujer, Gineclinic, S.C
Aug 5, 2021

Stroke Rehabilitation Trial in Taiwan (mirror therapy (MT), augmented reality (AR), Control intervention)

Not yet recruiting
  • Stroke Rehabilitation
  • mirror therapy (MT)
  • +2 more
  • New Taipei City, Taiwan
  • +4 more
Aug 13, 2023

Leukemia, Erythroblastic, Acute, MDS Trial in New York (5-Azacytidine, Fludarabine, Melphalan)

Completed
Has Results
  • Leukemia, Erythroblastic, Acute
  • Myelodysplastic Syndromes
  • New York, New York
    Weill Cornell Medical College
Aug 25, 2021

Pertussis Immunisation, Diphtheria Immunisation, Tetanus Immunisation Trial in Cape Town (Tetanus Toxoid, Reduced Diphtheria

Recruiting
  • Pertussis Immunisation
  • +3 more
  • Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine
  • Cape Town, South Africa
  • +2 more
Dec 2, 2022

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma Trial in Australia (AMP945 ascending doses, AMP945 RP2D)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • AMP945 ascending doses
  • AMP945 RP2D
  • St Leonards, New South Wales, Australia
  • +6 more
Dec 7, 2022

Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax in combination with azacitidine and CAG
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 20, 2022

HIV Trial in Rochester, Seattle (gp160 Vaccine (Immuno-AG), rgp120/HIV-1IIIB, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • +4 more
  • Rochester, New York
  • +1 more
Oct 28, 2021

Sarcomas, Melanomas, Germ Cell Tumors Trial run by the NCI (AeroEclipse II Breath Actuated Nebulizer, Bintrafusp alfa,

Withdrawn
  • Sarcomas
  • +4 more
  • AeroEclipse II Breath Actuated Nebulizer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 16, 2021

Stroke Trial in Chicago (Upper limb-based movement priming (UL-priming), Stimulation-based priming (Stim priming), Lower

Not yet recruiting
  • Stroke
  • Upper limb-based movement priming (UL-priming)
  • +3 more
  • Chicago, Illinois
    Brain Plasticity Lab
Jun 15, 2023

Abortion in First Trimester Trial in Singapore (Letrozole, Mifepristone)

Not yet recruiting
  • Abortion in First Trimester
  • Singapore, Singapore
    KK Women's and Children's Hospital
Apr 17, 2022

Clear Cell Renal Cell Carcinoma Trial in Duarte, Nashville (XmAb819)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • XmAb819
  • Duarte, California
  • +1 more
Jun 20, 2022

Chronic Granulomatous Disease X-linked (X-CGD) Trial in Rome, Milan (Ibuprofen, Myelostim, Mozobil)

Recruiting
  • Chronic Granulomatous Disease X-linked (X-CGD)
  • Rome, Lazio, Italy
  • +1 more
Oct 27, 2022

HIV Trial in Seattle (HIVAC-1e, gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • HIVAC-1e
  • gp160 Vaccine (MicroGeneSys)
  • Seattle, Washington
    Children's Hospital & Medical Center / Seattle ACTU
Oct 26, 2021